help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Kretser, D. M.
Right arrow Articles by Jenkin, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Kretser, D. M.
Right arrow Articles by Jenkin, G.

Endocrinology, Vol 134, 1231-1237, Copyright © 1994 by Endocrine Society


ARTICLES

The isolation of activin from ovine amniotic fluid

DM de Kretser, LM Foulds, M Hancock, J McFarlane, N Goss and G Jenkin
Institute of Reproduction and Development, Monash University, Clayton, Victoria, Australia.

During a study of the levels of inhibin and follistatin in ovine amniotic fluid, we noted that although detectable levels of immunoactive inhibin and follistatin were found throughout gestation, the addition of amniotic fluid to a rat anterior pituitary cell culture resulted in a stimulation, rather than the expected suppression, of FSH concentrations. These data suggested the possibility that activin was present in amniotic fluid. We, therefore, set out to isolate the molecules responsible for this activin-like activity and determine their structure. Amniotic fluid, collected from pregnant sheep between 120-140 days gestation, was used as starting material in the purification and diluted in parallel to a human activin-A standard in the activin RIA employed to monitor the purification. A total pool of 7.4 liters amniotic fluid was processed by dye affinity chromatography, hydrophobic interactive chromatography, gel filtration, and a series of reverse phase HPLC steps. Polyacrylamide gel electrophoresis of fractions from the final HPLC step, which showed both activin immunoactivity and bioactivity, revealed a band with a mol wt of 25.3 kilodaltons (kDa), which reduced to 15.8 kDa, and a minor band of 45 kDa, which reduced to 25 kDa. NH2-terminal amino acid sequences of several active fractions from the same region were identical to the known sequence of ovine activin-A. The identification of immunoactive activin, follistatin, and inhibin in amniotic fluid raises the question of the sites of production of these proteins and their interactions and role in fetal physiology.


This article has been cited by other articles:


Home page
EndocrinologyHome page
J. R. McFarlane, L. M. Foulds, A. E. O’Connor, D. J. Phillips, G. Jenkin, M. T. W. Hearn, and D. M. de Kretser
Uterine Milk Protein, a Novel Activin-Binding Protein, Is Present in Ovine Allantoic Fluid
Endocrinology, October 1, 1999; 140(10): 4745 - 4752.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
L. M. Foulds, D. M. de Kretser, P. Farnworth, D. Buttress, G. Jenkin, N. P. Groome, and J. R. McFarlane
Ovine Allantoic Fluid Contains High Concentrations of Activin A: Partial Dissociation of Immunoactivity and Bioactivity
Biol Reprod, August 1, 1998; 59(2): 233 - 240.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society